Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Niacin, N-3 Fatty Acids and Insulin Resistance

This study has been completed.
Information provided by:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Identifier:
First received: February 2, 2006
Last updated: April 30, 2013
Last verified: April 2013